CompletedNot applicableNCT04586816

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

Studying Hyperpigmentation of the skin

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Integrative Skin Science and Research
Principal Investigator
Raja K Sivamani, MD
Integrative Skin Science and Research
Intervention
1% red maple leaf extract in cream base(combination_product)
Enrollment
19 target
Eligibility
30-70 years · FEMALE
Timeline
20192020

Study locations (1)

Collaborators

Verdure Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04586816 on ClinicalTrials.gov

Other trials for Hyperpigmentation of the skin

Additional recruiting or active studies for the same condition.

See all trials for Hyperpigmentation of the skin

← Back to all trials